000 01378 a2200385 4500
005 20250513192935.0
264 0 _c19991221
008 199912s 0 0 eng d
022 _a0706-7437
024 7 _a10.1177/070674379904400709
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDursun, S M
245 0 0 _aOlanzapine for patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study.
_h[electronic resource]
260 _bCanadian journal of psychiatry. Revue canadienne de psychiatrie
_cSep 1999
300 _a701-4 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aBenzodiazepines
650 0 4 _aDrug Resistance
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aOlanzapine
650 0 4 _aPirenzepine
_xanalogs & derivatives
650 0 4 _aProspective Studies
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
700 1 _aGardner, D M
700 1 _aBird, D C
700 1 _aFlinn, J
773 0 _tCanadian journal of psychiatry. Revue canadienne de psychiatrie
_gvol. 44
_gno. 7
_gp. 701-4
856 4 0 _uhttps://doi.org/10.1177/070674379904400709
_zAvailable from publisher's website
999 _c10458035
_d10458035